Cargando…
High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888
BACKGROUND: Many proteins that are dysregulated or mutated in cancer cells rely on the molecular chaperone HSP90 for their proper folding and activity, which has led to considerable interest in HSP90 as a cancer drug target. The diverse array of HSP90 client proteins encompasses oncogenic drivers, c...
Autores principales: | Lyman, Susan K., Crawley, Suzanne C., Gong, Ruoyu, Adamkewicz, Joanne I., McGrath, Garth, Chew, Jason Y., Choi, Jennifer, Holst, Charles R., Goon, Leanne H., Detmer, Scott A., Vaclavikova, Jana, Gerritsen, Mary E., Blake, Robert A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049797/ https://www.ncbi.nlm.nih.gov/pubmed/21408192 http://dx.doi.org/10.1371/journal.pone.0017692 |
Ejemplares similares
-
Correction: High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888
por: Lyman, Susan K., et al.
Publicado: (2011) -
XL888 limits vemurafenib-induced proliferative skin events by suppressing paradoxical MAPK activation
por: Phadke, Manali, et al.
Publicado: (2015) -
miR-888: Hit it when you see it!
por: Bader, Andreas G
Publicado: (2014) -
Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
por: Lemasson, Benjamin, et al.
Publicado: (2016) -
888. Improving outcomes with revised preoperative universal decolonization protocol
por: Gnass, Silvia I
Publicado: (2020)